Abstract
The development of new drugs against tuberculosis and diphtheria is focused on disrupting the biogenesis of the cell wall, the unique architecture of which confers resistance against current therapies. The enzymatic pathways involved in the synthesis of the cell wall by these pathogens are well understood but the underlying regulatory mechanisms are largely unknown.
Original language | English |
---|---|
Article number | 122 |
Journal | BMC Biology |
Volume | 11 |
DOIs | |
Publication status | Published - 30 Dec 2013 |